These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1477628)

  • 1. Diffuse field loss and central visual function in glaucoma.
    Lachenmayr BJ; Drance SM
    Ger J Ophthalmol; 1992; 1(2):67-73. PubMed ID: 1477628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse field loss and diffuse retinal nerve-fiber loss in glaucoma.
    Lachenmayr BJ; Drance SM; Airaksinen PJ
    Ger J Ophthalmol; 1992; 1(1):22-5. PubMed ID: 1477613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increased threshold for detection of phase differences in pattern-induced color flicker fusion in patients with glaucoma].
    Tritsch MF; Pfeiffer N
    Klin Monbl Augenheilkd; 1994 Jul; 205(1):27-32. PubMed ID: 7933905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between foveal threshold and visual acuity using the Humphrey visual field analyzer.
    Flaxel CJ; Samples JR; Dustin L
    Am J Ophthalmol; 2007 May; 143(5):875-7. PubMed ID: 17452176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function.
    Wall M; White WN
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):134-42. PubMed ID: 9430554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of glaucoma on central visual function.
    Stamper RL
    Trans Am Ophthalmol Soc; 1984; 82():792-826. PubMed ID: 6398938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of the 76-suprathreshold visual field test to detect eyes with visual field defect by Humphrey threshold testing in a population-based setting: the Thessaloniki eye study.
    Topouzis F; Coleman AL; Yu F; Mavroudis L; Anastasopoulos E; Koskosas A; Pappas T; Dimitrakos S; Wilson MR
    Am J Ophthalmol; 2004 Mar; 137(3):420-5. PubMed ID: 15013863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability?
    Bengtsson B; Heijl A
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2201-4. PubMed ID: 10892863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of moderate smoking on the central visual field.
    Akarsu C; Yazici B; Taner P; Ergin A
    Acta Ophthalmol Scand; 2004 Aug; 82(4):432-5. PubMed ID: 15291937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foveal color and luminance sensitivity losses in glaucoma.
    Kelly JP; Fourman SM; Jindra LF
    Ophthalmic Surg Lasers; 1996 Mar; 27(3):179-87. PubMed ID: 8833122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scanning laser polarimetry using variable corneal compensation in the detection of glaucoma with localized visual field defects.
    Kook MS; Cho HS; Seong M; Choi J
    Ophthalmology; 2005 Nov; 112(11):1970-8. PubMed ID: 16185765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency-doubling technology: searching for the optimum diagnostic criteria for glaucoma.
    Ferreras A; Larrosa JM; Polo V; Pajarín AB; Mayoral F; Honrubia FM
    Acta Ophthalmol Scand; 2007 Feb; 85(1):73-9. PubMed ID: 17244214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foveal and non-foveal measures of short wavelength sensitive pathways in glaucoma and ocular hypertension.
    Heron G; Adams AJ; Husted R
    Ophthalmic Physiol Opt; 1987; 7(4):403-4. PubMed ID: 3454916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of the dicon screening field to detect eyes with glaucomatous field loss by Humphrey threshold testing.
    Huang AS; Smith SD; Quigley HA
    J Glaucoma; 1998 Jun; 7(3):158-64. PubMed ID: 9627854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in contrast sensitivity in glaucoma patients].
    Dimofte AD; Rusu V; Dimofte G
    Oftalmologia; 2004; 48(3):72-6. PubMed ID: 15598055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffuse and localized glaucomatous visual field changes in light sense, flicker and visual acuity perimetry. Evidence of pressure damage].
    Lachenmayr BJ; Drance SM; Chauhan BC; House PH; Lalani S
    Fortschr Ophthalmol; 1991; 88(5):530-7. PubMed ID: 1757044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The different effects of aging on normal sensitivity in flicker and light-sense perimetry.
    Lachenmayr BJ; Kojetinsky S; Ostermaier N; Angstwurm K; Vivell PM; Schaumberger M
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2741-8. PubMed ID: 8188467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.